Pharmaceutical

BioCryst Pharmaceuticals gets grant for inhibitors of the complement system for disease treatment

Discover how BioCryst Pharmaceuticals' patent for complement system inhibitors offers groundbreaking treatment options for various diseases.

May 3, 2024 - 00:00
Discover how BioCryst Pharmaceuticals' patent for complement system inhibitors offers groundbreaking treatment options for various diseases.
Read the original article

Tags:

Previous Article

Vertex Pharmaceuticals gets grant for treatment of alpha-1 antitrypsin deficienc...

Next Article

Astellas Pharma gets grant for novel carbocyclic prolinamide derivatives for tre...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Chronic diseases “as urgent as climate change,” says Novo Nordisk CSO

Chronic diseases “as urgent as climate change,” says No...

Oct 4, 2024

STAT+: Life sciences deals on track to hit lowest point since 2017

STAT+: Life sciences deals on track to hit lowest point...

Oct 12, 2023

Sterilisation Solutions, Equipment and Services for the Pharmaceutical Industry

Sterilisation Solutions, Equipment and Services for the...

Oct 2, 2024